Device Trial Radar · NCT05854095
The Study for Evaluation of Acute Phase Safety and Efficacy of 'Pivot Bridge' to Short-term Treat FTR
Last checked: Nov 20, 2026Latest source record: Feb 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Mar 13, 2023
Primary completion
Oct 17, 2023
Study completion Dec 27, 2023
Sponsor
- Lead sponsor
- Tau-MEDICAL Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 11, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
evaluation of safety and efficacy of 'Pivot Bridge' to short-term treat Functional Tricuspid regurgitation
Conditions
- Functional Tricuspid Regurgitation
Interventions
Pivot BridgeDevice
transcatheter for short-term treat Functional Tricuspid regurgitation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of Acute phase safetyTime frame: immediately after the procedure
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Bucheon Sejong Hospital
Bucheon-si, South Korea
Samsung Medical Center
Seoul, South Korea
Keimyung University Dongsan Hospital
Daegu, Dalseo-gu, South Korea
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.